Pre-order Enquiry
Request Free Sample
Global Synthetic Lethality-based Drugs and Targets Market Research Report 2023
SKU ID : QYR-23471733 | Publishing Date : 11-Apr-2023
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Synthetic Lethality-based Drugs and Targets Market Research Report 2023
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Synthetic Lethality-based Drugs and Targets Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Synthetic Lethality-based Drugs and Targets Market Perspective (2018-2029)
2.2 Synthetic Lethality-based Drugs and Targets Growth Trends by Region
2.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Synthetic Lethality-based Drugs and Targets Historic Market Size by Region (2018-2023)
2.2.3 Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Region (2024-2029)
2.3 Synthetic Lethality-based Drugs and Targets Market Dynamics
2.3.1 Synthetic Lethality-based Drugs and Targets Industry Trends
2.3.2 Synthetic Lethality-based Drugs and Targets Market Drivers
2.3.3 Synthetic Lethality-based Drugs and Targets Market Challenges
2.3.4 Synthetic Lethality-based Drugs and Targets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue
3.1.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue (2018-2023)
3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Players (2018-2023)
3.2 Global Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Synthetic Lethality-based Drugs and Targets Revenue
3.4 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio
3.4.1 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Synthetic Lethality-based Drugs and Targets Revenue in 2022
3.5 Synthetic Lethality-based Drugs and Targets Key Players Head office and Area Served
3.6 Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
3.7 Date of Enter into Synthetic Lethality-based Drugs and Targets Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Synthetic Lethality-based Drugs and Targets Breakdown Data by Type
4.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Type (2018-2023)
4.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2024-2029)
5 Synthetic Lethality-based Drugs and Targets Breakdown Data by Application
5.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Application (2018-2023)
5.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2018-2029)
6.2 North America Synthetic Lethality-based Drugs and Targets Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023)
6.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2018-2029)
7.2 Europe Synthetic Lethality-based Drugs and Targets Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023)
7.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size (2018-2029)
8.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2018-2023)
8.4 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size (2018-2029)
9.2 Latin America Synthetic Lethality-based Drugs and Targets Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023)
9.4 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size (2018-2029)
10.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023)
10.4 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Introduction
11.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Introduction
11.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 BeiGene
11.3.1 BeiGene Company Detail
11.3.2 BeiGene Business Overview
11.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Introduction
11.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.3.5 BeiGene Recent Development
11.4 Clovis Oncology
11.4.1 Clovis Oncology Company Detail
11.4.2 Clovis Oncology Business Overview
11.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Introduction
11.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.4.5 Clovis Oncology Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Introduction
11.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Introduction
11.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 AtlasMedx
11.7.1 AtlasMedx Company Detail
11.7.2 AtlasMedx Business Overview
11.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Introduction
11.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.7.5 AtlasMedx Recent Development
11.8 Chordia Therapeutics
11.8.1 Chordia Therapeutics Company Detail
11.8.2 Chordia Therapeutics Business Overview
11.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.8.5 Chordia Therapeutics Recent Development
11.9 IDEAYA Biosciences
11.9.1 IDEAYA Biosciences Company Detail
11.9.2 IDEAYA Biosciences Business Overview
11.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Introduction
11.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.9.5 IDEAYA Biosciences Recent Development
11.10 Mission Therapeutics
11.10.1 Mission Therapeutics Company Detail
11.10.2 Mission Therapeutics Business Overview
11.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.10.5 Mission Therapeutics Recent Development
11.11 Repare Therapeutics
11.11.1 Repare Therapeutics Company Detail
11.11.2 Repare Therapeutics Business Overview
11.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.11.4 Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.11.5 Repare Therapeutics Recent Development
11.12 Sierra Oncology
11.12.1 Sierra Oncology Company Detail
11.12.2 Sierra Oncology Business Overview
11.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Introduction
11.12.4 Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.12.5 Sierra Oncology Recent Development
11.13 SyntheX Labs
11.13.1 SyntheX Labs Company Detail
11.13.2 SyntheX Labs Business Overview
11.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Introduction
11.13.4 SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
11.13.5 SyntheX Labs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Synthetic Lethality-based Drugs and Targets Market Research Report 2023
List of TablesTable 1. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Synthetic Lethality-based Drugs and Targets Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Synthetic Lethality-based Drugs and Targets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Synthetic Lethality-based Drugs and Targets Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Synthetic Lethality-based Drugs and Targets Market Share by Region (2018-2023)
Table 8. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Synthetic Lethality-based Drugs and Targets Market Share by Region (2024-2029)
Table 10. Synthetic Lethality-based Drugs and Targets Market Trends
Table 11. Synthetic Lethality-based Drugs and Targets Market Drivers
Table 12. Synthetic Lethality-based Drugs and Targets Market Challenges
Table 13. Synthetic Lethality-based Drugs and Targets Market Restraints
Table 14. Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Synthetic Lethality-based Drugs and Targets Market Share by Players (2018-2023)
Table 16. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2022)
Table 17. Ranking of Global Top Synthetic Lethality-based Drugs and Targets Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
Table 21. Date of Enter into Synthetic Lethality-based Drugs and Targets Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2018-2023)
Table 25. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2024-2029)
Table 27. Global Synthetic Lethality-based Drugs and Targets Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2018-2023)
Table 29. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2024-2029)
Table 31. North America Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) & (US$ Million)
Table 46. AbbVie Company Detail
Table 47. AbbVie Business Overview
Table 48. AbbVie Synthetic Lethality-based Drugs and Targets Product
Table 49. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Synthetic Lethality-based Drugs and Targets Product
Table 54. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. BeiGene Company Detail
Table 57. BeiGene Business Overview
Table 58. BeiGene Synthetic Lethality-based Drugs and Targets Product
Table 59. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 60. BeiGene Recent Development
Table 61. Clovis Oncology Company Detail
Table 62. Clovis Oncology Business Overview
Table 63. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product
Table 64. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 65. Clovis Oncology Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product
Table 69. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Synthetic Lethality-based Drugs and Targets Product
Table 74. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. AtlasMedx Company Detail
Table 77. AtlasMedx Business Overview
Table 78. AtlasMedx Synthetic Lethality-based Drugs and Targets Product
Table 79. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 80. AtlasMedx Recent Development
Table 81. Chordia Therapeutics Company Detail
Table 82. Chordia Therapeutics Business Overview
Table 83. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product
Table 84. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 85. Chordia Therapeutics Recent Development
Table 86. IDEAYA Biosciences Company Detail
Table 87. IDEAYA Biosciences Business Overview
Table 88. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product
Table 89. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 90. IDEAYA Biosciences Recent Development
Table 91. Mission Therapeutics Company Detail
Table 92. Mission Therapeutics Business Overview
Table 93. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product
Table 94. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 95. Mission Therapeutics Recent Development
Table 96. Repare Therapeutics Company Detail
Table 97. Repare Therapeutics Business Overview
Table 98. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product
Table 99. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 100. Repare Therapeutics Recent Development
Table 101. Sierra Oncology Company Detail
Table 102. Sierra Oncology Business Overview
Table 103. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product
Table 104. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 105. Sierra Oncology Recent Development
Table 106. SyntheX Labs Company Detail
Table 107. SyntheX Labs Business Overview
Table 108. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product
Table 109. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million)
Table 110. SyntheX Labs Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Synthetic Lethality-based Drugs and Targets Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Synthetic Lethality-based Drugs and Targets Market Share by Type: 2022 VS 2029
Figure 3. Monotherapy Features
Figure 4. Combination Therapy Features
Figure 5. Global Synthetic Lethality-based Drugs and Targets Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2022 VS 2029
Figure 7. Medical Research Institution Case Studies
Figure 8. Hospital and Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Synthetic Lethality-based Drugs and Targets Report Years Considered
Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Synthetic Lethality-based Drugs and Targets Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Synthetic Lethality-based Drugs and Targets Market Share by Region: 2022 VS 2029
Figure 14. Global Synthetic Lethality-based Drugs and Targets Market Share by Players in 2022
Figure 15. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2022
Figure 17. North America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Synthetic Lethality-based Drugs and Targets Market Share by Country (2018-2029)
Figure 19. United States Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Synthetic Lethality-based Drugs and Targets Market Share by Country (2018-2029)
Figure 23. Germany Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Region (2018-2029)
Figure 31. China Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Country (2018-2029)
Figure 39. Mexico Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Country (2018-2029)
Figure 43. Turkey Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 46. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 47. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 48. Clovis Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 51. AtlasMedx Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 52. Chordia Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 53. IDEAYA Biosciences Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 54. Mission Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 55. Repare Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 56. Sierra Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 57. SyntheX Labs Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Keyplayers in Global Synthetic Lethality-based Drugs and Targets Market Research Report 2023
AbbVieAstraZeneca
BeiGene
Clovis Oncology
GlaxoSmithKline
Pfizer
AtlasMedx
Chordia Therapeutics
IDEAYA Biosciences
Mission Therapeutics
Repare Therapeutics
Sierra Oncology
SyntheX Labs
